chronic myeloproliferative disease Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

University of Washington (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadgilbert's syndrome

I am/have/hadsecondary myelofibrosis

I am/have/hadtumor burden

I am/have/hadstem cell transplantation

I am/have/hadblood count

I am/have/hadbone marrow procedure

I am/have/hadblast crisis

I am/have/hadmyelofibrosis

I am/have/hadhemolysis

I am/have/hadhyperleukocytosis

I am/have/hadmyelodysplastic syndromes

I am/have/hadblood cell count

I am/have/hadmyelodysplastic/myeloproliferative disease

I am/have/hadleukostasis

I am/have/hadtumor cells

I am/have/hadblood cell counts

I am/have/hadpolycythemia

I am/have/hadleukemia

I am/have/hadmyeloproliferative disorder

I am/have/hadmyeloproliferative neoplasm

added new label for I am/have/had

more

I am looking for

I am looking forruxolitinib

I am looking forfedratinib

I am looking fordecitabine

I am looking forthiamine

I am looking forcytarabine

I am looking forhydroxyurea

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Decitabine, with ruxolitinib or fedratinib, may work better than multi-agent chemotherapy or no pre-transplant therapy, in treating patients with accelerated/blast phase myeloproliferative neoplasms.

gilbert's syndrome

secondary myelofibrosis

thiamine

ruxolitinib

tumor burden

0 views
16 Feb, 2024
1 location

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.